A citation-based method for searching scientific literature


List of co-cited articles
1 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Renal Hemodynamic Function and RAAS Activation Over the Natural History of Type 1 Diabetes.
Yuliya Lytvyn, Petter Bjornstad, Julie A Lovshin, Genevieve Boulet, Mohammed A Farooqi, Vesta Lai, Josephine Tse, Leslie Cham, Leif E Lovblom, Alanna Weisman,[...]. Am J Kidney Dis 2019
10
66


Bromocriptine versus levodopa in early Parkinson's disease.
J J van Hilten, C C Ramaker, Rl Stowe, N J Ives. Cochrane Database Syst Rev 2007
15
33

Obesity and the built environment.
Katie M Booth, Megan M Pinkston, Walker S Carlos Poston. J Am Diet Assoc 2005
311
33

A systematic review of built environment and health.
Arlene Renalds, Tracey H Smith, Patty J Hale. Fam Community Health 2010
182
33


Bromocriptine induced pleuropulmonary fibrosis.
J Wiggins, C Skinner. Thorax 1986
33
33

Dopamine: Functions, Signaling, and Association with Neurological Diseases.
Marianne O Klein, Daniella S Battagello, Ariel R Cardoso, David N Hauser, Jackson C Bittencourt, Ricardo G Correa. Cell Mol Neurobiol 2019
201
33


Built Environment, Selected Risk Factors and Major Cardiovascular Disease Outcomes: A Systematic Review.
Pasmore Malambo, Andre P Kengne, Anniza De Villiers, Estelle V Lambert, Thandi Puoane. PLoS One 2016
106
33


Therapeutic Potential of Polyphenols in the Management of Diabetic Neuropathy.
Md Tanvir Kabir, Nuzhat Tabassum, Md Sahab Uddin, Faissal Aziz, Tapan Behl, Bijo Mathew, Md Habibur Rahman, Raushanara Akter, Abdur Rauf, Lotfi Aleya. Evid Based Complement Alternat Med 2021
11
33

Bromocriptine: a novel approach to the treatment of type 2 diabetes.
H Pijl, S Ohashi, M Matsuda, Y Miyazaki, A Mahankali, V Kumar, R Pipek, P Iozzo, J L Lancaster, A H Cincotta,[...]. Diabetes Care 2000
159
33

Impacting the Remedial Potential of Nano Delivery-Based Flavonoids for Breast Cancer Treatment.
Rakesh K Sindhu, Rishu Verma, Twinkle Salgotra, Md Habibur Rahman, Muddaser Shah, Rokeya Akter, Waheed Murad, Sidra Mubin, Parveen Bibi, Safaa Qusti,[...]. Molecules 2021
7
33

Role of built environments in physical activity, obesity, and cardiovascular disease.
James F Sallis, Myron F Floyd, Daniel A Rodríguez, Brian E Saelens. Circulation 2012
539
33


The many faces of diabetes: a disease with increasing heterogeneity.
Tiinamaija Tuomi, Nicola Santoro, Sonia Caprio, Mengyin Cai, Jianping Weng, Leif Groop. Lancet 2014
337
33

Accidental bromocriptine ingestion in childhood.
S H Vermund, R G Goldstein, A A Romano, S J Atwood. J Pediatr 1984
4
33


Update on the treatment of type 2 diabetes mellitus.
Juan José Marín-Peñalver, Iciar Martín-Timón, Cristina Sevillano-Collantes, Francisco Javier Del Cañizo-Gómez. World J Diabetes 2016
226
33

Molecular cloning and expression of the gene for a human D1 dopamine receptor.
A Dearry, J A Gingrich, P Falardeau, R T Fremeau, M D Bates, M G Caron. Nature 1990
617
33

Sulfonylureas and their use in clinical practice.
Daniele Sola, Luca Rossi, Gian Piero Carnevale Schianca, Pamela Maffioli, Marcello Bigliocca, Roberto Mella, Francesca Corlianò, Gian Paolo Fra, Ettore Bartoli, Giuseppe Derosa. Arch Med Sci 2015
191
33

A review of alpha-glucosidase inhibitors from plants as potential candidates for the treatment of type-2 diabetes.
Amina M Dirir, Marianne Daou, Ahmed F Yousef, Lina F Yousef. Phytochem Rev 2022
14
33

Dopaminergic drugs in type 2 diabetes and glucose homeostasis.
Felicitas Lopez Vicchi, Guillermina Maria Luque, Belen Brie, Juan Patricio Nogueira, Isabel Garcia Tornadu, Damasia Becu-Villalobos. Pharmacol Res 2016
50
33


Bromocriptine: old drug, new formulation and new indication.
R I G Holt, A H Barnett, C J Bailey. Diabetes Obes Metab 2010
58
33

Drug therapy: Bromocriptine.
D Parkes. N Engl J Med 1979
149
33

Effect of bromocriptine-QR (a quick-release formulation of bromocriptine mesylate) on major adverse cardiovascular events in type 2 diabetes subjects.
J Michael Gaziano, Anthony H Cincotta, Aaron Vinik, Lawrence Blonde, Nancy Bohannon, Richard Scranton. J Am Heart Assoc 2012
67
33

Fate and disposition of bromocriptine in animals and man. I: structure elucidation of the metabolites.
G Maurer, E Schreier, S Delaborde, H R Loosli, R Nufer, A P Shukla. Eur J Drug Metab Pharmacokinet 1982
35
33


The link between family history and risk of type 2 diabetes is not explained by anthropometric, lifestyle or genetic risk factors: the EPIC-InterAct study.
R A Scott, C Langenberg, S J Sharp, P W Franks, O Rolandsson, D Drogan, Y T van der Schouw, U Ekelund, N D Kerrison, E Ardanaz,[...]. Diabetologia 2013
141
33

Resveratrol and Neuroprotection: Impact and Its Therapeutic Potential in Alzheimer's Disease.
Md Habibur Rahman, Rokeya Akter, Tanima Bhattacharya, Mohamed M Abdel-Daim, Saad Alkahtani, Mohammed W Arafah, Norah S Al-Johani, Norah M Alhoshani, Nora Alkeraishan, Alhanof Alhenaky,[...]. Front Pharmacol 2020
47
33

Type 2 diabetes.
Sudesna Chatterjee, Kamlesh Khunti, Melanie J Davies. Lancet 2017
866
33

Association between family history of diabetes and clusters of adherence to healthy behaviors: cross-sectional results from the Health Examinees-Gem (HEXA-G) study.
Jaesung Choi, Ji-Yeob Choi, Sang-Ah Lee, Kyoung-Mu Lee, Aesun Shin, Juhwan Oh, JooYong Park, Minkyo Song, Jae Jeong Yang, Jong-Koo Lee,[...]. BMJ Open 2019
8
33

Metformin: from mechanisms of action to therapies.
Marc Foretz, Bruno Guigas, Luc Bertrand, Michael Pollak, Benoit Viollet. Cell Metab 2014
699
33


Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control.
Helena W Rodbard, Paul S Jellinger, Jaime A Davidson, Daniel Einhorn, Alan J Garber, George Grunberger, Yehuda Handelsman, Edward S Horton, Harold Lebovitz, Philip Levy,[...]. Endocr Pract 2009
682
33



Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1.
R K Sunahara, H C Guan, B F O'Dowd, P Seeman, L G Laurier, G Ng, S R George, J Torchia, H H Van Tol, H B Niznik. Nature 1991
33


Central dopamine D2 receptors regulate plasma glucose levels in mice through autonomic nerves.
Hiroko Ikeda, Naomi Yonemochi, Risa Mikami, Manabu Abe, Meiko Kawamura, Rie Natsume, Kenji Sakimura, John L Waddington, Junzo Kamei. Sci Rep 2020
6
33

Novel dopamine receptors half a decade later.
P Sokoloff, J C Schwartz. Trends Pharmacol Sci 1995
243
33


Susceptible and protective human leukocyte antigen class II alleles and haplotypes in bahraini type 2 (non-insulin-dependent) diabetes mellitus patients.
Ayesha A Motala, Marc Busson, Einas M Al-Harbi, Manal A A Khuzam, Emtiaz M D Al-Omari, Mona R Arekat, Wassim Y Almawi. Clin Diagn Lab Immunol 2005
13
33


Dopamine receptors: from structure to function.
C Missale, S R Nash, S W Robinson, M Jaber, M G Caron. Physiol Rev 1998
33

Is air quality index associated with cardiometabolic risk factors in adolescents? The CASPIAN-III Study.
Parinaz Poursafa, Marjan Mansourian, Mohammad-Esmaeil Motlagh, Gelayol Ardalan, Roya Kelishadi. Environ Res 2014
41
33

Obesity and type 2 diabetes in children: epidemiology and treatment.
Elizabeth R Pulgaron, Alan M Delamater. Curr Diab Rep 2014
165
33



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.